Quick Answer
Biomea Fusion, Inc. reported Research And Development Expense of $61.98 million for the year ending 2025.
- Biomea Fusion, Inc. showed a decrease of -47.5% in Research And Development Expense from 2024 to 2025.
- This data is from Biomea Fusion, Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $334.0 thousand | Q2 2020: $216.0 thousand | Q3 2020: $789.0 thousand | Q4 2020: $2.33 million | Q1 2021: $3.80 million | Q2 2021: $5.22 million | Q3 2021: $7.89 million | Q4 2021: $11.09 million | Q1 2022: $11.35 million | Q2 2022: $12.58 million | Q3 2022: $18.24 million | Q4 2022: $20.54 million | Q1 2023: $24.40 million | Q2 2023: $21.94 million | Q3 2023: $25.35 million | Q4 2023: $30.87 million | Q1 2024: $33.78 million | Q2 2024: $31.83 million | Q3 2024: $27.24 million | Q4 2024: $25.24 million | Q1 2025: $22.90 million | Q2 2025: $16.57 million | Q3 2025: $14.40 million.
- Over the full 7 years of available data (2019 to 2025), Biomea Fusion, Inc.'s Research And Development Expense has grown by 5,575.7%.
- Historical annual values: Fiscal year 2025: $61.98 million | Fiscal year 2024: $118.09 million | Fiscal year 2023: $102.55 million | Fiscal year 2022: $62.71 million | Fiscal year 2021: $28.00 million | Fiscal year 2020: $3.67 million | Fiscal year 2019: $1.09 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: